B3GALNT2 and hepatocellular carcinoma: Consistent with the data from HCC patients (Fig. 1), B3GALNT2 was also upregulated in most HCC cell lines compared with the normal liver cell line L02 cells in both mRNA and protein levels (Fig. 2a, b).